746P EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors
Peter H. O'Donnell,Matthew D. Galsky,Jonathan E. Rosenberg,Daniel P. Petrylak,Arjun Vasant Balar,Bradley Alexander McGregor,Elisabeth I. Heath,Evan Y. Yu,David I. Quinn,Noah M. Hahn,Mary S. Campbell,S-Y. Liang,Joyce Steinberg,Y. Loriot